Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04131556 · ClinicalTrials.gov registry record · Phase 1
A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult Participants
A Phase 1 study, sponsored by Shire.
- Terminated
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT04131556 is a Phase 1 study that was terminated before completion, run by Shire. The registered enrollment target is 20 participants.
The verdict
NCT04131556, a Phase 1 study, was terminated before completion, sponsored by Shire.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The Purpose of this study is to assess the relative bioavailability, dose proportionality, the impact of food on the rate and extent of absorption, palatability of the selected pediatric formulation of maribavir and the safety and tolerability of two candidate pediatric formulations and the adult tablet formulation of maribavir in healthy participants.
Interventions
- DRUG Maribavir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-10-25 |
| Est. Completion | 2020-01-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04131556
The ClinicalTrials.gov registry entry for NCT04131556 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Maribavir is the first listed.
NCT04131556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04131556 about?
NCT04131556 is a clinical study titled "A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult Participants". The Purpose of this study is to assess the relative bioavailability, dose proportionality, the impact of food on the rate and extent of absorption, palatability of the selected pediatric formulation of maribavir and the safety and tolerability of two candidate pediatric formulations and the adult ta...
What is the current status of trial NCT04131556?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2019-10-25. Estimated completion is 2020-01-06.
What interventions are being tested in trial NCT04131556?
The interventions under investigation include: Maribavir (DRUG).
Who is sponsoring clinical trial NCT04131556?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.